| abstract |
Compositions useful for increasing the effectiveness of the α-2-adrenergic agonist component include a carrier component, an α-2-adrenergic agonist component, a solubility-enhancing component that helps to dissolve the α-2-adrenergic agonist component. contains. In one embodiment, the α-2-adrenergic agonist component includes an α-2-adrenergic agonist. In other embodiments, the solubility enhancing component comprises carboxymethyl cellulose. |